Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏
View:
Post by jopatclo on Nov 12, 2024 7:50am

Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

Bravo  Now 4.0 Europe & Canada
Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.

With its new capabilities, Ventripoint 4.0 provides additional insights, including:
3D Tensors: Visualise the direction and magnitude of surface changes.
4D Motion: Simulate a dynamic heart model across the cardiac cycle.
3D Global Strain: Assess longitudinal, circumferential, and total surface area changes.
3D Heat Map: Visualise surface area changes in a new heat map view.
3D Segmentation: Access a detailed polar map for surface area change analysis.
Ventripoint Diagnostics Ltd. hashtagCardiacImaging hashtagInnovation
 
 
Comment by jopatclo on Nov 12, 2024 9:58am
Richard SimpsonRichard Simpson • Following • FollowingInsight Scientist | Intelligent Engagement | Life Science Investor and Consultant | Former Crime SolverInsight Scientist | Intelligent Engagement | Life Science Investor and Consultant | Former Crime Solver Visit my website 26m • 26 minutes ago   Ventripoint Diagnostics Ltd.'s next ...more  
Comment by jopatclo on Nov 13, 2024 7:27am
@Bob123 le clown remember 24-11-2023 low = 0.135 & 08-01-2024 high = 0.36 before the FDA V4.0 and Sales Now 4.0 Europe & Canada & Now @Bob123 CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of ...more  
Comment by jopatclo on Nov 13, 2024 2:26pm
@cardinal his entire focus every day is Ventripoint. Look for key material news right away   8 about 4 hours ago   @cardinal lol--come on early. buy a few...have a great day...   6 about 4 hours ago   @marcge81 @cardinal what timeframe is " right away "?   2 about 3 hours ago  ...more  
Comment by jopatclo on Nov 13, 2024 3:47pm
good comment @hassy dont write off 2024 yet. May not be the "break out year" that we are all looking for, but sales are coming in and having a "record" year in sales is not a difficult bar to hit. @JohnnyUtah Thank you for your sacrifice Rocket, I'm also not really buying much these days, until I see some forward progress, it will remain a hold for me.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities